Making Health Care Better with Partnership and Progress: 2018 in Review
This year we covered a wide range of stories with impact on health care and medicine at the local, national, and international levels. From the human and economic toll of the ongoing opioid crisis to efforts to make health care better for people with complex medical conditions and social factors, our goal was to capture a snapshot of the system.
Help Wanted: Businesses Must Join the Effort to End Opioid Abuse
Addressing the human and economic toll of opioid use disorder will require the shared commitment of private, public, and nonprofit sectors, according to a Boston Globe op-ed co-authored by Partners HealthCare President and CEO David Torchiana, MD, Blue Cross Blue Shield of Massachusetts' Andrew Dreyfus, and Boston Medical Center's Kate Walsh.
An Extension of the Care Team, a Lifeline for Patients with Addictions
Chuck Tuttle doesn’t interact directly with patients very often. Yet his impact on care for patients with substance use disorders (SUDs) within Partners HealthCare is, in many instances, life-changing—even life-saving.
Combatting the Opioid Epidemic, By Increasing Access to Life-Saving Treatments
Partners HealthCare member Neighborhood Health Plan (NHP) is launching a first-of-its kind initiative to increase access to life-saving treatments for those struggling with substance use disorders.
Patient Experience Summit Highlights Patient-Centered Care for Addiction
If the clinicians, quality specialists, and administrators gathered at the third annual Partners HealthCare Patient Experience Summit took away one message regarding treating patients with substance use disorders, it was this: Treat these patients as if they have any other chronic illness like heart disease, diabetes, or HIV.
At MGH, a Massachusetts First for Opioid-Addicted Patients
When patients with diabetes or high blood pressure present in the emergency department (ED), physicians can offer medications for treatment. For opioid-addicted patients, however, ED doctors are rarely able to offer the standard-of-care medication buprenorphine, despite its demonstrated efficacy in easing addiction’s grip.